CMS Open Payments · Program Year 2024
New Jersey
New Jersey received $64,839,399.34 in pharmaceutical-industry payments to 24,169 physicians and 38 teaching hospitals across 532,833 transactions.
- $64.8M
- Total payments
- $53.0M
- To physicians
- $6.3M
- To teaching hospitals
- #16
- of 59 states
In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $64.8M in payments to 24,169 physicians and 38 teaching hospitals in New Jersey. That ranks New Jersey #16 of 59 states and territories (0.5% of the US total), averaging $2.2K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.
The verdict
New Jersey pairs above-median payment volume with a physician-heavy payment mix.
- #16
- of 59 states
- 0.5%
- of the national total
- 81.7%
- to physicians vs. hospitals
- 24,169
- physicians paid
What the Data Shows for New Jersey
New Jersey sits in the high-volume tercile at #16 of 59 by all-tracks dollars (0.5% of the US total): $64,839,399.34 across 532,833 PY2024 transactions.
Physician versus hospital mix is near the corpus middle (81.7% / 9.8%). Average transaction $121.69. Leading nature of payment: "Compensation for Services Other Than Consulting" at $17.3M (26.7% of the state file; top-three natures 69.0%).
New Jersey sits in the 75th percentile (mid-pack). Just above: Arizona ($67.8M). Just below: Colorado ($63.4M). For context: top-ranked California ($342.4M) is 5.3× larger than New Jersey. CMS Sunshine Act framework and methodology.
Physician vs Hospital Payments
How pharmaceutical payments in New Jersey are distributed between physicians and teaching hospitals.
Physician Payments
$53.0M
81.7% of total · 24,169 recipients · $2.2K avg
Teaching Hospital Payments
$6.3M
9.8% of total · 38 hospitals · $166.9K avg
Payment Breakdown by Type
New Jersey has 16 types of pharmaceutical payments. "Compensation for Services Other Than Consulting" accounts for 26.7%.
Nature concentration in New Jersey
Top three Open Payments natures are 69.0% of state dollars; residual is every other reported nature
Payment categories in New Jersey
Top categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of State |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $17.3M | 6,854 | 26.7% |
| Consulting Fee | $14.8M | 4,381 | 22.8% |
| Food and Beverage | $12.6M | 497,646 | 19.5% |
| Royalty or License | $4.8M | 261 | 7.4% |
| Travel and Lodging | $4.6M | 14,698 | 7.0% |
| Grant | $2.9M | 150 | 4.5% |
| Debt Forgiveness | $2.3M | 590 | 3.5% |
| Education | $1.6M | 5,471 | 2.5% |
| Honoraria | $1.2M | 494 | 1.9% |
| Compensation for Faculty or Speaker (Medical Education) | $886.4K | 429 | 1.4% |
| Long-Term Medical Supply or Device Loan | $804.4K | 717 | 1.2% |
| Acquisitions | $486.3K | 11 | 0.8% |
| Space Rental or Facility Fees | $399.2K | 137 | 0.6% |
| Gift | $101.8K | 820 | 0.2% |
| Entertainment | $12.9K | 161 | 0.0% |
| Charitable Contribution | $9.9K | 13 | 0.0% |
Read with this New Jersey Open Payments read
Volume neighbors, physician-share peers, and the national nature catalog, not the same three guides on every state page.
- Next higher total: Arizona ($67.8M)
- Next lower total: Colorado ($63.4M)
- Nearest physician-share mix: Oregon (81.6% to physicians)
- Nearest physician-share mix: Illinois (81.6% to physicians)
- Nearest physician-share mix: Texas (82.1% to physicians)
- National catalog for leading nature here: Compensation for Services Other Th… (26.7% of New Jersey)
- State payment rankings (includes New Jersey at #16)
- How Open Payments natures are defined
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.
Read our methodology - how this data is sourced, computed, and verified.
Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024
What New Jersey totals can and cannot tell you
The aggregate payment figure for New Jersey measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.
Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.